International Genetic Epidemiology Society – Jan 2026
Dr. Blue was elected President-Elect of IGES and will again serve on the Board of Directors, this time as an Officer.
Dr. Blue was elected President-Elect of IGES and will again serve on the Board of Directors, this time as an Officer.
Xue et al. (2025) Training competencies and recommendations for the next generation of public health genetics: Reflections from current leaders in the field We surveyed dozens of experts across several professions to assess the appropriate skills and knowledge needed for a career in the interdisciplinary field of public health genetics. Focus group discussions underwent thematic
Xue et al. (2025) Risk score roulette: A cautionary tale of polygenic risk score reliability Given the strong interest in using genome-wide association study results to infer individual-level risk of Alzheimer’s disease, we assessed the performance of several polygenic risk score approaches. While each approach was significantly associated with dementia risk with similar performance in
Blue et al. (2025) Multi-ancestry meta-analysis identifies genetic modifiers of age-at-onset of Alzheimer’s disease at known and novel loci We performed a genome-wide association study for age-at-onset of Alzheimer’s disease (AD) in two diverse cohorts. The 16 loci significantly associated with age-at-onset of AD in the meta-analysis include several AD risk loci as well as
Faino et al. (2025) CHP2 modifies chronic Pseudomonas aeruginosa airway infection risk in cystic fibrosis Taking advantage of longitudinal clinical data for nearly 5,000 people with Cystic Fibrosis (CF), we performed a genome-wide association study for time to chronic Pa infection. We identified a common noncoding variant near the gene CHP2 significantly associated with a